Pages that link to "Q34534951"
Jump to navigation
Jump to search
The following pages link to Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. (Q34534951):
Displaying 50 items.
- Concepts and Controversies in Evaluating Vitamin K Status in Population-Based Studies (Q26771243) (← links)
- Proper Calcium Use: Vitamin K2 as a Promoter of Bone and Cardiovascular Health (Q26771939) (← links)
- Mechanisms of arterial calcifications and consequences for cardiovascular function (Q26821993) (← links)
- Are there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease? (Q27002431) (← links)
- Sailing between Scylla and Charybdis: oral long-term anticoagulation in dialysis patients (Q27006930) (← links)
- Vitamin k dependent proteins and the role of vitamin k2 in the modulation of vascular calcification: a review (Q27692568) (← links)
- New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs) (Q28081366) (← links)
- High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K2, A pre-post intervention clinical trial (Q33776200) (← links)
- Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients. (Q34241519) (← links)
- Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms (Q34461476) (← links)
- Vitamin k intake and plasma desphospho-uncarboxylated matrix Gla-protein levels in kidney transplant recipients (Q34464708) (← links)
- Assessment of potential biomarkers of subclinical vitamin K deficiency in patients with end-stage kidney disease (Q35147833) (← links)
- Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study (Q35553851) (← links)
- Associations between Thyroid Hormones, Calcification Inhibitor Levels and Vascular Calcification in End-Stage Renal Disease (Q35684042) (← links)
- Gas6 protein: its role in cardiovascular calcification (Q36031853) (← links)
- Growth arrest-specific gene 6 (Gas6) levels are elevated in patients with chronic renal failure (Q36389223) (← links)
- Functional deficiency of vitamin K in hemodialysis patients in Upper Silesia in Poland (Q36820196) (← links)
- Vitamin K status and vascular calcification: evidence from observational and clinical studies (Q36828717) (← links)
- The role of vitamin K in soft-tissue calcification (Q36828721) (← links)
- Vascular calcification in chronic kidney disease: Pathogenesis and clinical implication (Q37195354) (← links)
- Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients (Q37278038) (← links)
- Vitamin K status in chronic kidney disease (Q37357929) (← links)
- A systems biology preview of the relationships between mineral and metabolic complications in chronic kidney disease. (Q37365294) (← links)
- Coronary artery calcification in chronic kidney disease: An update. (Q37722763) (← links)
- Vitamin D and vascular calcification in chronic kidney disease (Q37892311) (← links)
- Role of vitamin K-dependent proteins in the arterial vessel wall (Q37895509) (← links)
- Mechanisms and treatment of extraosseous calcification in chronic kidney disease (Q37902504) (← links)
- Vascular and Valvular Calcification in Chronic Peritoneal Dialysis Patients (Q37914009) (← links)
- Vitamin K status in chronic kidney disease: a report of a study and a mini-review (Q38072360) (← links)
- Vascular calcification: an update on mechanisms and challenges in treatment (Q38086058) (← links)
- Vitamin K antagonists: beyond bleeding (Q38176662) (← links)
- The realm of vitamin K dependent proteins: shifting from coagulation toward calcification. (Q38199459) (← links)
- Public health relevance of drug-nutrition interactions. (Q38651214) (← links)
- Does statins promote vascular calcification in chronic kidney disease? (Q38776273) (← links)
- A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors. (Q38801820) (← links)
- The role of vitamin K in vascular calcification of patients with chronic kidney disease (Q38851700) (← links)
- Biomarkers of Renal Function: Towards Clinical Actionability (Q39368726) (← links)
- Role of vascular calcification inhibitors in preventing vascular dysfunction and mortality in hemodialysis patients (Q39369106) (← links)
- Vitamin K-Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis (Q40397629) (← links)
- CALU polymorphism A29809G affects calumenin availability involving vascular calcification (Q41139964) (← links)
- The Role of Vitamin K Status in Cardiovascular Health: Evidence from Observational and Clinical Studies (Q41625344) (← links)
- Evolving calciphylaxis--what randomized, controlled trials can contribute to the capture of rare diseases (Q42569047) (← links)
- Calcimimetics and outcomes in CKD. (Q42727545) (← links)
- Desphospho-Uncarboxylated Matrix-Gla Protein Is Increased Postoperatively in Cardiovascular Risk Patients. (Q47230064) (← links)
- Should vitamin K be supplemented instead of antagonised in patients with idiopathic pulmonary fibrosis? (Q47230370) (← links)
- Prevalence and Effects of Functional Vitamin K Insufficiency: The PREVEND Study (Q47239503) (← links)
- Novel oral anticoagulants in patients with chronic kidney disease and atrial fibrillation (Q47365787) (← links)
- Effect of Vitamin K on Vascular Health and Physical Function in Older People with Vascular Disease--A Randomised Controlled Trial. (Q48894187) (← links)
- Prognostic value of cardiovascular calcifications in hemodialysis patients: a longitudinal study. (Q50020990) (← links)
- [Anticoagulation in patients with chronic kidney disease : Recommendations from the working group "Heart-Kidney" of the German Cardiac Society and the German Society of Nephrology]. (Q52840065) (← links)